Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain fo... Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer’s disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.02 | 0.02 | 0.02 | 72000 | 0.02 | DE |
| 4 | -0.003 | -13.0434782609 | 0.023 | 0.023 | 0.018 | 131782 | 0.02031634 | DE |
| 12 | 0.004 | 25 | 0.016 | 0.024 | 0.013 | 437434 | 0.0173354 | DE |
| 26 | -0.004 | -16.6666666667 | 0.024 | 0.034 | 0.013 | 441024 | 0.02175937 | DE |
| 52 | 0.009 | 81.8181818182 | 0.011 | 0.034 | 0.007 | 413676 | 0.02161428 | DE |
| 156 | 0.01 | 100 | 0.01 | 0.034 | 0.005 | 572512 | 0.014374 | DE |
| 260 | 0.01 | 100 | 0.01 | 0.034 | 0.005 | 572512 | 0.014374 | DE |
Zadie420
3分前
stink stack
4分前
Cambreau
4分前
work-n-hard
5分前
Mozy429
6分前
jupiter
7分前
timberwolf7
8分前
rodman
9分前
JP313
10分前
MusicExec
10分前
swim
10分前
Grouse Hunter
10分前
WhatMoney?
10分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。